Home > Archive>Volume 15, Issue 10, 2022 >1634-1640. DOI:10.18240/ijo.2022.10.11
PDF HTML XML Export Cite reminder
Risk factors for the long-term prognosis and recurrence of HIV-negative cytomegalovirus retinitis in North China
Author:
Corresponding Author:

Zhu-Yun Qian. Beijing GIANTMED Medical Diagnostics Lab, No.37, Lanxi Park, Renhe Town, Shunyi District, Beijing 101300, China. qianzhuyun552@126.com; Yong Tao. Department of Ophthalmology, Beijing Chaoyang Hospital, Capital Medical University, No.8, South Road of Worker’s Stadium, Chaoyang District, Beijing 100020, China. taoyong@bjcyh.com

Fund Project:

Supported by National Natural Science Foundation of China (No.82070948); Beijing Talent Project (No.2020027); Shunyi District “Beijing Science and Technology Achievements Transformation Coordination and Service Platform” Construction Fund (No.SYGX202010).

  • Article
    • | |
  • Metrics
    • |
  • Reference [34]
    • |
  • Related [20]
    • | | |
  • Comments
    Abstract:

    AIM: To demonstrate the clinical features, the risk factors, the visual prognosis and the recurrence of cytomegalovirus (CMV) retinitis (CMVR) in HIV-negative patients. METHODS: HIV-negative patients with CMVR were involved in this study. Best corrected visual acuity (BCVA), intraocular pressure (IOP), CMV-DNA load in aqueous and/or serum samples, treatment, follow-up time, recurrence and complications were recorded. Ocular characteristics were evaluated by fundus photographs. Association between ocular factors and visual prognosis were analyzed by regression analysis. RESULTS: Twenty-five eyes of 16 patients were included. All 25 eyes underwent intravitreal injections of anti-viral agents. The mean logMAR BCVA improved from 0.94±0.98 (0.98-0.78) initially to 0.77±0.73 (0.82-0.68) at last visit, but not significantly. After antiviral treatment, the aqueous CMV DNA load significantly reduced to (3.42±1.47)×102 copies/mL (P=0.001), compared with (2.51±3.11)×105 copies/mL at baseline. Macular involvement (R2=0.475, P=0.049) and initial visual acuity (R2=0.475, P=0.017) were significantly associated with the poor visual prognosis (BCVA<20/400). The extent of retinal lesions (R2=0.064, P=0.04) was significant associated with the risk of recurrence of CMVR. CONCLUSION: Intravitreal injection of anti-viral agents offers a safe and effective treatment for CMVR. Macular involvement and initial visual acuity significantly associate with visual prognosis. The extent of retinal lesions is significantly associated with the recurrence of CMVR. These ocular factors can be used as predictive risk factors for long term visual prognosis in HIV-negative CMVR patients.

    Reference
    1 Munro M, Yadavalli T, Fonteh C, Arfeen S, Lobo-Chan AM. Cytomegalovirus retinitis in HIV and non-HIV individuals. Microorganisms 2019;8(1):E55.
    2 Silva F, Ficher KN, Viana L, Coelho I, Rezende JT, Wagner D, Vaz ML, Foresto R, Silva Junior HT, Pestana JM. Presumed cytomegalovirus retinitis late after kidney transplant. J Bras Nefrol 2021:S0101-28002021005039302.
    3 Tátá CF, Ramires T, Piteira M, Matono R, Guz C. Cytomegalovirus retinitis as a sole manifestation of HIV infection. Cureus 2021; 13(10):e18642.
    4 Shapira Y, Mimouni M, Vishnevskia-Dai V. Cytomegalovirus retinitis in HIV-negative patients - associated conditions, clinical presentation, diagnostic methods and treatment strategy. Acta Ophthalmol 2018;96(7):e761-e767.
    5 Sugar EA, Jabs DA, Ahuja A, Thorne JE, Danis RP, Meinert CL,. Incidence of cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Am J Ophthalmol 2012;153(6):1016-1024.e5.
    6 Holland GN. AIDS and ophthalmology: the first quarter century. Am J Ophthalmol 2008;145(3):397-408.e1.
    7 Jabs DA. AIDS and ophthalmology, 2008. Arch Ophthalmol 2008; 126(8):1143.
    8 Samia L, Hamam R, Dbaibo G, Saab R, El-Solh H, Abboud M, Muwakkit S. Cytomegalovirus retinitis in children and young adults with acute lymphoblastic leukemia in Lebanon. Leuk Lymphoma 2014;55(8):1918-1921.
    9 Lee JJ, Teoh SCB, Chua JLL, Tien MCH, Lim TH. Occurrence and reactivation of cytomegalovirus retinitis in systemic lupus erythematosus with normal CD4 counts. Eye (Lond) 2006;20(5): 618-621.
    10 Bertelmann E, Liekfeld A, Pleyer U, Hartmann C. Cytomegalovirus retinitis in Wegener’s granulomatosis: case report and review of the literature. Acta Ophthalmol Scand 2005;83(2):258-261.
    11 Eid AJ, Bakri SJ, Kijpittayarit S, Razonable RR. Clinical features and outcomes of cytomegalovirus retinitis after transplantation. Transplant Infect Dis 2008;10(1):13-18.
    12. Xhaard A, Robin M, Scieux C, de Latour RP, Deplus S, Mazeron MC, Devergie A, Espérou H, Rocha V, Gluckman E, Ribaud P, Socié G. Increased incidence of cytomegalovirus retinitis after allogeneic hematopoietic stem cell transplantation. Transplantation 2007;83(1):80-83.
    13 Kim JY, Hong SY, Park WK, Kim RY, Kim M, Park YG, Kim HJ, Lee S, Lee DG, Park YH. Prognostic factors of cytomegalovirus retinitis after hematopoietic stem cell transplantation. PLoS One 2020;15(9):e0238257.
    14 Ocieczek P, Barnacle JR, Gumulira J, Phiri S, Heller T, Grabska-Liberek I. Cytomegalovirus retinitis screening and treatment in human immunodeficiency virus patients in Malawi: a feasibility study. Open Forum Infect Dis 2019;6(11):ofz439.
    15 Al-Farsi N, Al Jabri S. Cytomegalovirus retinitis in children post hematopoietic stem cell transplantation: can we develop a screening protocol? Oman J Ophthalmol 2022;15(1):1-2.
    16 Chen WB, Long Z, Hou J, Miao H, Zhao MW. Continuous High-Dose (6 mg) vs. Low-Dose (3 mg) Intravitreal Ganciclovir for Cytomegalovirus Retinitis After Haploidentical Hematopoietic Stem Cell Transplantation: a Randomized Controlled Study. Front Med (Lausanne) 2021;8:750760.
    17 Tátá CF, Ramires T, Piteira M, Matono R, Guz C. Cytomegalovirus retinitis as a sole manifestation of HIV infection. Cureus 2021; 13(10):e18642.
    18 Holland GN, Van Natta ML, Goldenberg DT, Ritts R Jr, Jr D, Jabs DA, Studies of Ocular Complications of AIDS Research Group. Relationship between opacity of cytomegalovirus retinitis lesion borders and severity of immunodeficiency among people with AIDS. Invest Ophthalmol Vis Sci 2019;60(6):1853-1862.
    19 Chen C, Guo CG, Meng L, Yu J, Xie LY, Dong HW, Wei WB. Comparative analysis of cytomegalovirus retinitis and microvascular retinopathy in patients with acquired immunodeficiency syndrome. Int J Ophthalmol 2017;10(9):1396-1401.
    20 Šimeková K, Nováková E, Rosoľanka R, Masná J, Antolová D. Clinical course of opportunistic infections-toxoplasmosis and cytomegalovirus infection in HIV-infected patients in Slovakia. Pathogens 2019;8(4):219.
    21 Grover S, Fishman GA, Anderson RJ, Tozatti MSV, Heckenlively JR, Weleber RG, Edwards AO, Brown J Jr. Visual acuity impairment in patients with retinitis pigmentosa at age 45y or older. Ophthalmology 1999;106(9):1780-1785.
    22 Holland GN, Vaudaux JD, Jeng SM, Yu F, Goldenberg DT, Folz IC, Cumberland WG, McCannel CA, Helm CJ, Hardy WD, UCLA CMV Retinitis Study Group. Characteristics of untreated AIDS-related cytomegalovirus retinitis. I. Findings before the era of highly active antiretroviral therapy (1988 to 1994). Am J Ophthalmol 2008; 145(1):5-11.
    23 Standardization of uveitis nomenclature for reporting clinical data. results of the first international workshop. Am J Ophthalmol 2005;140(3):509-516.
    24 Agarwal A, Kumari N, Trehan A, Khadwal A, Dogra MR, Gupta V, Sharma A, Gupta A, Singh R. Outcome of cytomegalovirus retinitis in immunocompromised patients without Human Immunodeficiency Virus treated with intravitreal ganciclovir injection. Graefes Arch Clin Exp Ophthalmol 2014;252(9):1393-1401.
    25 Qian ZY, Li HL, Tao Y, Li WS. Initial intravitreal injection of high-dose ganciclovir for cytomegalovirus retinitis in HIV-negative patients. BMC Ophthalmol 2018;18(1):314.
    26 Murray J, Hilbig A, Soe TT, Ei WLSS, Soe KP, Ciglenecki I. Treating HIV-associated cytomegalovirus retinitis with oral valganciclovir and intra-ocular ganciclovir by primary HIV clinicians in southern Myanmar: a retrospective analysis of routinely collected data. BMC Infect Dis ⰲ‰匲田朻椲琰愨‱匩ⰺ‸刴攲愮氼ⵢ瑲椾洲攷†偘䍩剥†晌潙爬†潃捨略汮愠牃‬挠祋瑯潮浧攠杗慊氬漠癄極爠畋獆‬椠湇晵敯挠瑃楇漬渠⁄獯瑮畧搠祈⁗本爠潗略灩⸠⁗䑂椮愠杅湦潦獥瑣楴挠敦映晩楮捤慩捶祩⁤潵晡物敺慥汤ⴠ瑴楨浥敲⁡偰䍹删⁦景潲爠⁁潉捄畓氠慰牡⁴捩祥瑮潴浳攠杷慩汴潨瘠楣特畴獯楥湧晡敬捯瑶楩潲湵獳⸠⁲䝥牴慩敮晩整獩⁳䄠物据栠⁩䍮汴楲湡⁶䕩硴灲⁥佡灬栠瑧桡慮汣浩潣汬㉶どㅲ㠠㭩㉪㕥㙣⡴ㅩ㉯⥮㩳㈮㐠ㅉ㍮⵴㈠㑊㈠く⹰㱨扴牨㹡㍬㡭䭬眠漲渰‱䠹䨻ⰱ′匨漸温›䜱ⰳ‵䰱攭攱″䨵夵Ⱞ‼䭢楲派′䨸䜠ⱗ⁡䭮楧洠⁑奙䨬⸠⁓䍵汮椠湃楍挬愠汘⁵挠桂慈爬愠捔瑵攠牊楓猬琠楓捨獥愠獙献漠捓楹慮瑴敨摥⁳睩楳琬栠⁰瑨桹敳⁩摣敯癣敨汥潭灩浣敡湬琠⁰潲景⁰捥祲獴瑩潥楳搠⁡浮慤挠畯汣慵牬⁡敲搠数浨慡⁲業湡⁣灯慫瑩楮敥湴瑩獣⁳眠楯瑦栠⁴捨祥瑲潭浯敳来慮汳潩癴楩牶略猠⁩牮攠瑳楩湴極琠楨獹⹤⁲䵯楧捥牬潳漠牦杯慲渠楧獡浮獣⁩㉣ぬ㉯ㅶ㭩㥲⠠㙩⥮㨠ㅣㅹㅴ㑯⹭㱥执牡㹬㍯㥶⁩卲敵穳朠楲湥⁴䕩Ɱ⁩䅴湩⁳倠ⱴ⁲坥楡湴歭汥敮牴‮䌠䅄⹲⁵䡧漠獄瑥杩敶渠攲琰椱挸猻′漵昨‱挩示琵漹洭收朹愮氼潢癲椾爲甹猠⁄灥愠瑃桬潥杲散湱攠獅椮猠⹔⁲䙩牢潵湴瑥†䝴敯渠敪瑯⁨㉮〠ㅃ㤮㬠ㅭち㩲㙴ㅩ㙮⸠at the twentieth anniversary of the breakthrough of tenofovir in the treatment of HIV infections. Viruses 2021;13(12):2410.
    30 Fan JJ, Tao Y, Hwang DK. Comparison of intravitreal ganciclovir monotherapy and combination with foscarnet as initial therapy for cytomegalovirus retinitis. Int J Ophthalmol 2018;11(10):1638-1642.
    31 Munro M, Yadavalli T, Fonteh C, Arfeen S, Lobo-Chan AM. Cytomegalovirus retinitis in HIV and non-HIV individuals. Microorganisms 2019;8(1):E55.
    32 Axer-Siegel R, Dotan A, Mimouni K, Bor E, Weinberger D, Bourla DH. Intravitreous bevacizumab treatment for macular edema due to central retinal vein occlusion. Curr Eye Res 2012;37(9):818-822.
    33 Liu F, Kwok AKH, Cheung BMY. The efficacy of intravitreal vancomycin and dexamethasone in the treatment of experimental bacillus cereus endophthalmitis. Curr Eye Res 2008;33(9):761-768.
    34 Qian ZY, Chen X, Tao Y, Li WS, Gu W. Prognostic factors of cytomegalovirus infection associated retinitis in HIV-negative patients: a retrospective cohort study. Ocular Immunol Inflamm 2021; 29(1):154-159.
    35 Styczynski J. Who is the patient at risk of CMV recurrence: a review of the current scientific evidence with a focus on hematopoietic cell transplantation. Infect Dis Ther 2018;7(1):1-16.
    36 Devilliers MJ, Ben Hadj Salah W, Barreau E, Da Cunha E, M'Garrech M, Bénichou J, Labetoulle M, Rousseau A. Ocular manifestations of viral diseases. Rev Med Interne 2021;42(6):401-410.
    37 Miyazaki D, Shimizu D, Shimizu Y, Inoue Y, Inoue T, Higaki S, Ueta M
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

Yan-Hong Shi, Hui Wang, Hao Kang,/et al.Risk factors for the long-term prognosis and recurrence of HIV-negative cytomegalovirus retinitis in North China. Int J Ophthalmol, 2022,15(10):1634-1640

Copy
Share
Article Metrics
  • Abstract:426
  • PDF: 728
  • HTML: 0
  • Cited by: 0
Publication History
  • Received:December 01,2021
  • Revised:July 19,2022
  • Online: September 21,2022
You are the 4403362 Visitors
Governing Body：Department of Health, Provincial Government of Shaanxi, China
Organizer：Xi'an Medical Association of China
Address：Room 11707-08, Building 2, Unit 1, Wanda Plaza, No.8 Yanta North Road, Xi'an 710054, Shaanxi Province, China
Fax：(8629)82245172 Phone：(+8629)82245172/82210956
Email：ijopress@163.com
International Journal of Ophthalmology ® 2025 All Rights Reserved   The terms of CC BY-NC-ND 4.0 are applicable to all open access content.